Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMax experience.
Munteanu
Mona
M
Biopredictive, and Groupe Hospitalier Pitié Salpêtrière, 47-83 Boulevard de l'Hopital, Paris, France. mona.munteanu@biopredictive.com
Ratziu
Vlad
V
Morra
Rachel
R
Messous
Djamila
D
Imbert-Bismut
Francoise
F
Poynard
Thierry
T
D015415:Biomarkers / Q000097:blood*; D003937:Diagnosis, Differential; D005234:Fatty Liver / Q000097:blood* / Q000150:complications / Q000175:diagnosis; D006505:Hepatitis / Q000097:blood* / Q000150:complications / Q000175:diagnosis; D006801:Humans; D008103:Liver Cirrhosis / Q000097:blood* / Q000150:complications / Q000175:diagnosis; D008403:Mass Screening / Q000379:methods*; D024821:Metabolic Syndrome / Q000097:blood / Q000150:complications*; D012307:Risk Factors
D015415:Biomarkers